LIF anticorps
Aperçu rapide pour LIF anticorps (ABIN327898)
Antigène
Voir toutes LIF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Recognizes recombinant human Leukemia Inhibitory Factor (LIF) and to endogenous protein. Cross reactivity was observed against recombinant murine LIF. No reactivity was observed with recombinant rat LIF.
-
Purification
- Protein G purified
-
Immunogène
-
Monoclonal recombinant human Leukemia Inhibitory Factor (LIF).
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Indications d'application
-
Approved: WB (1 μg/mL)
Usage: Suitable for use in Western Blot. Western Blot: 1 μg/mL.
Not recommended for: IHC-P -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.6, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- avoid freeze thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Autre désignation
- LIF
-
Sujet
-
Name/Gene ID: LIF
Synonyms: LIF, DIA, Emfilermin, HILDA, Melanoma-derived LPL inhibitor, MLPLI, Leukemia inhibitory factor, CDF, D factor, Human interleukin in DA cells -
ID gène
- 3976
-
UniProt
- P15018
-
Pathways
- Signalistation JAK/STAT, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Antigène
-